Skip to main content
logo
Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
0.3923
-0.0175 (-4.27%)
Jul 20, 2026, 10:24 AM EDT - Market open

Immutep Revenue

Immutep had revenue of 4.10M AUD in the half year ending December 31, 2025, with 4,506.79% growth. This brings the company's revenue in the last twelve months to 51.77K, down -2.90% year-over-year. In the fiscal year ending June 30, 2025, Immutep had annual revenue of 59.71K, down -49.86%.

Revenue (ttm)
51.77K AUD
Revenue Growth
-2.90%
P/S Ratio
9.74
Revenue / Employee
1,670 AUD
Employees
31
Market Cap
51.45M USD

Revenue Chart

Chart
* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202559.71K-59.38K-49.86%
Jun 30, 2024119.09K-72.63K-37.88%
Jun 30, 2023191.72K-62.67K-24.63%
Jun 30, 2022254.39K-58.45K-18.68%
Jun 30, 2021312.84K-7.45M-95.97%
Jun 30, 20207.77M6.47M499.78%
Jun 30, 20191.29M-2.34M-64.42%
Jun 30, 20183.64M2.84M354.63%
Jun 30, 2017800.46K625.41K357.27%
Jun 30, 2016175.05K--
Jun 30, 2015---
Jun 30, 2014---
Jun 30, 2013---
Jun 30, 2012---
Jun 30, 2011---
Jun 30, 2010---
Jun 30, 2009---
Jun 30, 2008---
Jun 30, 2007---
Jun 30, 2006---
Jun 30, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Xilio Therapeutics53.48M
Radiopharm Theranostics10.86M
BeyondSpring1.88M
Seres Therapeutics1.15M
Mereo BioPharma Group500.00K
aTyr Pharma190.00K
INmune Bio50.00K
eXoZymes-700.00
Revenue Rankings

IMMP News

More News